Article ID Journal Published Year Pages File Type
8447103 European Journal of Cancer 2011 9 Pages PDF
Abstract
The study was supported by a research grant from Aventis and Pfizer.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer - A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
Authors
, , , , , , , , , ,